Literature DB >> 15590408

Basal CD34(+) cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor.

Javier de la Rubia, José I Lorenzo, Marta Torrabadella, Pedro Marín, Andrés Insunza, Miguel A Sanz.   

Abstract

We analyzed factors predicting CD34(+) cell mobilization and collection after granulocyte colony-stimulating factor (G-CSF) administration in 47 healthy donors. Basal CD34(+) cell count and sex were the two variables that significantly predicted a better CD34(+) cell mobilization, and greater age was the only variable associated with lower CD34+ cell yields.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15590408

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  3 in total

1.  Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors.

Authors:  Tetsuichi Yoshizato; Naoko Watanabe-Okochi; Yasuhito Nannya; Motoshi Ichikawa; Tsuyoshi Takahashi; Tomohiko Sato; Akiko Masuda; Yutaka Yatomi; Nelson Hirokazu Tsuno; Mineo Kurokawa; Koki Takahashi
Journal:  Int J Hematol       Date:  2013-05-22       Impact factor: 2.490

2.  Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.

Authors:  Farid Boulad; Tsiporah Shore; Koen van Besien; Caterina Minniti; Mihaela Barbu-Stevanovic; Sylvie Wiener Fedus; Fabiana Perna; June Greenberg; Danielle Guarneri; Vijay Nandi; Audrey Mauguen; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Haematologica       Date:  2018-02-01       Impact factor: 9.941

3.  Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Authors:  Kristina Hölig; Helmuth Schmidt; Gero Hütter; Michael Kramer; Raphael Teipel; Katharina Heidrich; Kristin Zimmer; Falk Heidenreich; Matthias Blechschmidt; Tigran Torosian; Rainer Ordemann; Frank Kroschinsky; Elke Rücker-Braun; Laszlo Gopsca; Eva Maria Wagner-Drouet; Uta Oelschlaegel; Alexander H Schmidt; Martin Bornhäuser; Gerhard Ehninger; Johannes Schetelig
Journal:  Bone Marrow Transplant       Date:  2020-10-07       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.